{
    "meta": {
        "found": 7480,
        "returned": 5,
        "limit": 5,
        "page": 1
    },
    "data": [
        {
            "uuid": "02d0d99c-968e-4131-9858-f91c33d777a7",
            "title": "Ola Electric aims for $10 billion IPO valuation amid festive sales By Investing.com",
            "description": "Ola Electric aims for $10 billion IPO valuation amid festive sales",
            "keywords": "",
            "snippet": "Published Dec 07, 2023 02:04PM ET\n\n© Reuters.\n\nBENGALURU - Ola Electric is moving swiftly towards its initial public offering (IPO), with plans to file its dra...",
            "url": "https://www.investing.com/news/stock-market-news/ola-electric-aims-for-10-billion-ipo-valuation-amid-festive-sales-93CH-3251954",
            "image_url": "https://i-invdn-com.investing.com/news/LYNXNPEC0D0AP_L.jpg",
            "language": "en",
            "published_at": "2023-12-07T19:04:56.000000Z",
            "source": "investing.com",
            "relevance_score": null,
            "entities": [
                {
                    "symbol": "SBKFF",
                    "name": "State Bank of India",
                    "exchange": null,
                    "exchange_long": null,
                    "country": "us",
                    "type": "equity",
                    "industry": "Financial Services",
                    "match_score": 28.881716,
                    "sentiment_score": 0.2023,
                    "highlights": [
                        {
                            "highlight": "The recent funding round for Ola Electric was led by Temasek and included significant contributions from the State Bank of India among others. The round totaled $998 million from investors including Alpha Wave and DIG investment, bringing the company's valuation to $5.4 billion post-funding in October.",
                            "sentiment": 0.2023,
                            "highlighted_in": "main_text"
                        }
                    ]
                }
            ],
            "similar": [
                {
                    "uuid": "0e4593aa-a09e-4a7f-9de0-7cc20e6be3f2",
                    "title": "Midcap Financial Investment Prices Baby Bonds",
                    "description": "BDC Midcap Financial Investment (MFIC) (formerly Apollo Investment) has priced their new baby bond issue. The issue prices at 8% for 3 million shares plus an over allotment of 450,000 shares (bonds). Kroll rates the issue BBB- Look for this issue to trade on the NASDAQ in the next week or so. The pricing term",
                    "keywords": "",
                    "snippet": "BDC Midcap Financial Investment (MFIC) (formerly Apollo Investment) has priced their new baby bond issue. The issue prices at 8% for 3 million shares plus an ov...",
                    "url": "https://innovativeincomeinvestor.com/midcap-financial-investment-prices-baby-bonds/",
                    "image_url": "https://innovativeincomeinvestor.com/wp-content/uploads/2019/12/logo-innovative-income-investor.png",
                    "language": "en",
                    "published_at": "2023-12-07T11:19:22.000000Z",
                    "source": "innovativeincomeinvestor.com",
                    "relevance_score": null,
                    "entities": [
                        {
                            "symbol": "AINV",
                            "name": "Apollo Investment Corporation",
                            "exchange": null,
                            "exchange_long": null,
                            "country": "us",
                            "type": "equity",
                            "industry": "Financial Services",
                            "match_score": 23.530746,
                            "sentiment_score": 0.5267,
                            "highlights": [
                                {
                                    "highlight": "BDC Midcap Financial Investment (MFIC) (formerly Apollo Investment) has priced their new baby bond issue. The issue prices at 8% for 3 million shares plus an over allotment of 450,000 shares (bonds).\n\nKroll rates the issue BBB-\n\nLook for this issue to trade on the NASDAQ in the next week or so.\n\nThe pricing term sheet can be found here.",
                                    "sentiment": 0.5267,
                                    "highlighted_in": "main_text"
                                }
                            ]
                        }
                    ]
                },
                {
                    "uuid": "2eec267d-cf0d-45e0-96b6-3777676bbe65",
                    "title": "The racial homeownership gap is widening. New rules might make it worse.",
                    "description": "Banks are facing tougher capital requirements, which will probably make mortgages pricier for cash-poor home buyers and hurt minority borrowers.",
                    "keywords": "",
                    "snippet": "Business The racial homeownership gap is widening. New rules might make it worse. Banks are facing tougher capital requirements -- which will probably make mort...",
                    "url": "https://www.washingtonpost.com/business/2023/12/07/minority-homeownership-gap-banks/",
                    "image_url": "https://www.washingtonpost.com/wp-apps/imrs.php?src=https://arc-anglerfish-washpost-prod-washpost.s3.amazonaws.com/public/DC62JA5L6M3SK7TTT7AN6DIMPM_size-normalized.JPG&w=1440",
                    "language": "en",
                    "published_at": "2023-12-07T11:00:25.000000Z",
                    "source": "washingtonpost.com",
                    "relevance_score": null,
                    "entities": [
                        {
                            "symbol": "FMCC",
                            "name": "Freddie Mac",
                            "exchange": null,
                            "exchange_long": null,
                            "country": "us",
                            "type": "equity",
                            "industry": "Financial Services",
                            "match_score": 21.080345,
                            "sentiment_score": 0.6686,
                            "highlights": [
                                {
                                    "highlight": "Advertisement\n\nOut of reach\n\nHigher financing costs already have put homeownership out of reach for most of these borrowers who qualified just two years ago: Before the Fed started raising interest rates, 3.4 million Black Americans were deemed “mortgage ready” based on their credit history and income, according to research by Freddie Mac.",
                                    "sentiment": 0.7003,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "By contrast, the newer mortgage companies aren’t banks and don’t have deposits, so they need to sell off a greater portion of the loans they make to Fannie Mae and Freddie Mac, the government-backed mortgage giants that help pump liquidity into the housing market.",
                                    "sentiment": 0.6369,
                                    "highlighted_in": "main_text"
                                }
                            ]
                        },
                        {
                            "symbol": "FMCKL",
                            "name": "Freddie Mac",
                            "exchange": null,
                            "exchange_long": null,
                            "country": "us",
                            "type": "equity",
                            "industry": "Financial Services",
                            "match_score": 21.080322,
                            "sentiment_score": 0.6686,
                            "highlights": [
                                {
                                    "highlight": "Advertisement\n\nOut of reach\n\nHigher financing costs already have put homeownership out of reach for most of these borrowers who qualified just two years ago: Before the Fed started raising interest rates, 3.4 million Black Americans were deemed “mortgage ready” based on their credit history and income, according to research by Freddie Mac.",
                                    "sentiment": 0.7003,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "By contrast, the newer mortgage companies aren’t banks and don’t have deposits, so they need to sell off a greater portion of the loans they make to Fannie Mae and Freddie Mac, the government-backed mortgage giants that help pump liquidity into the housing market.",
                                    "sentiment": 0.6369,
                                    "highlighted_in": "main_text"
                                }
                            ]
                        },
                        {
                            "symbol": "FMCCI",
                            "name": "Freddie Mac",
                            "exchange": null,
                            "exchange_long": null,
                            "country": "us",
                            "type": "equity",
                            "industry": "Financial Services",
                            "match_score": 21.080322,
                            "sentiment_score": 0.6686,
                            "highlights": [
                                {
                                    "highlight": "Advertisement\n\nOut of reach\n\nHigher financing costs already have put homeownership out of reach for most of these borrowers who qualified just two years ago: Before the Fed started raising interest rates, 3.4 million Black Americans were deemed “mortgage ready” based on their credit history and income, according to research by Freddie Mac.",
                                    "sentiment": 0.7003,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "By contrast, the newer mortgage companies aren’t banks and don’t have deposits, so they need to sell off a greater portion of the loans they make to Fannie Mae and Freddie Mac, the government-backed mortgage giants that help pump liquidity into the housing market.",
                                    "sentiment": 0.6369,
                                    "highlighted_in": "main_text"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "uuid": "347a62cd-e231-4be5-b75f-f9a1a67f4473",
            "title": "Wealthsimple Aims to Quadruple Assets to $74B in Five Years",
            "description": "Wealthsimple has grown rapidly, with assets rising about 10-fold to C$25 billion since 2018, thanks in part to slick advertising and some Hollywood star power.",
            "keywords": "",
            "snippet": "(Bloomberg) --Wealthsimple Financial Corp., the online investment platform backed by Canada’s billionaire Desmarais family, has set a target of quadrupling as...",
            "url": "https://www.wealthmanagement.com/technology/wealthsimple-aims-quadruple-assets-74b-five-years",
            "image_url": "https://www.wealthmanagement.com/sites/wealthmanagement.com/files/mike-katchen-wealthsimple.jpg",
            "language": "en",
            "published_at": "2023-12-07T18:47:00.000000Z",
            "source": "wealthmanagement.com",
            "relevance_score": null,
            "entities": [
                {
                    "symbol": "IGIFF",
                    "name": "IGM Financial Inc.",
                    "exchange": null,
                    "exchange_long": null,
                    "country": "us",
                    "type": "equity",
                    "industry": "Financial Services",
                    "match_score": 29.041681,
                    "sentiment_score": 0.34,
                    "highlights": [
                        {
                            "highlight": "Related: Wealthsimple Raises Money at $4 Billion Value; Drake Buys In\n\n“We’re adding about C$1 billion dollars of net deposits a month right now,” Katchen told analysts at IGM Financial Inc.’s investor conference Tuesday.",
                            "sentiment": 0.34,
                            "highlighted_in": "main_text"
                        }
                    ]
                }
            ],
            "similar": [
                {
                    "uuid": "122eda64-e47a-4769-bf33-1d93d334784e",
                    "title": "Brookfield Real Assets Vs. SJNK: Birds Of A Feather (NYSE:RA)",
                    "description": "Brookfield Real Assets Income Fund cut its distribution in August. Click here to see why we compare RA to a high yield bond ETF, SJNK.",
                    "keywords": "",
                    "snippet": "Adisak Lamphat/iStock via Getty Images\n\nThe Brookfield Real Assets Income Fund (NYSE:RA) took flight during the pandemic and did not touch down until August of ...",
                    "url": "https://seekingalpha.com/article/4656554-brookfield-real-assets-vs-sjnk-birds-of-a-feather",
                    "image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1423981599/image_1423981599.jpg?io=getty-c-w1536",
                    "language": "en",
                    "published_at": "2023-12-07T14:29:36.000000Z",
                    "source": "seekingalpha.com",
                    "relevance_score": null,
                    "entities": [
                        {
                            "symbol": "RA",
                            "name": "Brookfield Real Assets Income Fund Inc.",
                            "exchange": null,
                            "exchange_long": null,
                            "country": "us",
                            "type": "equity",
                            "industry": "Financial Services",
                            "match_score": 59.66668,
                            "sentiment_score": 0,
                            "highlights": [
                                {
                                    "highlight": "Adisak Lamphat/iStock via Getty Images\n\nThe Brookfield Real Assets Income Fund (NYSE:RA) took flight during the pandemic and did not touch down until August of this year.\n\nData by YCharts\n\nWe covered it when it took flight in 2020, and explained why the distribution was unsustainable.",
                                    "sentiment": 0,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "SJNK: Birds Of A Feather (NYSE:RA)",
                                    "sentiment": 0,
                                    "highlighted_in": "title"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "uuid": "12a5f95e-5763-4477-b504-c0932480c6c0",
            "title": "ATHA Energy Announces Upsizing of Financing to $22,840,000",
            "description": "NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.",
            "keywords": "",
            "snippet": "This advertisement has not loaded yet, but your article continues below.\n\nATHA Energy Announces Upsizing of Financing to $22,840,000\n\nArticle content NOT FOR DI...",
            "url": "https://financialpost.com/globe-newswire/atha-energy-announces-upsizing-of-financing-to-22840000",
            "image_url": "https://dcs-static.gprod.postmedia.digital/15.0.1/websites/images/fp/favicon-fp.ico",
            "language": "en",
            "published_at": "2023-12-07T18:45:56.000000Z",
            "source": "financialpost.com",
            "relevance_score": null,
            "entities": [
                {
                    "symbol": "NXE",
                    "name": "NexGen Energy Ltd.",
                    "exchange": null,
                    "exchange_long": null,
                    "country": "us",
                    "type": "equity",
                    "industry": "Energy",
                    "match_score": 22.139038,
                    "sentiment_score": 0.8207,
                    "highlights": [
                        {
                            "highlight": "ATHA holds the largest cumulative exploration package in each of the Athabasca Basin and Thelon Basin, two of the world’s most prominent basins for uranium discoveries, with 6.1 million total acres along with a 10% carried interest portfolio of claims in the Athabasca Basin operated by NexGen Energy Ltd. (TSX: NXE) and Iso Energy Ltd.",
                            "sentiment": 0.8207,
                            "highlighted_in": "main_text"
                        }
                    ]
                }
            ],
            "similar": []
        },
        {
            "uuid": "6fd5e8e8-404c-44fd-a211-33349b5d096e",
            "title": "Tesla loses legal challenge against Swedish strikes",
            "description": "Tesla has lost a legal battle with Sweden’s postal service as its fight with Scandinavian trade unions escalates.",
            "keywords": "",
            "snippet": "Emma Hansson, chairman of IF Metall, stands on strike outside Tesla's Service Centre in Segeltorp in Stockholm, Sweden - Jessica Gow/TT News Agency/via REUTERS\n...",
            "url": "https://uk.finance.yahoo.com/news/tesla-loses-legal-challenge-against-184214957.html?.tsrc=rss",
            "image_url": "https://s.yimg.com/ny/api/res/1.2/_u6cKqRYlxW6DOClhw4Heg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03NTA-/https://media.zenfs.com/en/the_telegraph_818/2df202f4f8745b8f6d1da6cdafb694bd",
            "language": "en",
            "published_at": "2023-12-07T18:42:14.000000Z",
            "source": "finance.yahoo.com",
            "relevance_score": null,
            "entities": [
                {
                    "symbol": "FRBA",
                    "name": "First Bank",
                    "exchange": null,
                    "exchange_long": null,
                    "country": "us",
                    "type": "equity",
                    "industry": "Financial Services",
                    "match_score": 4.92855,
                    "sentiment_score": -0.8176,
                    "highlights": [
                        {
                            "highlight": "That said, as we expect mortgage rates to stay around 5pc until we near the first Bank Rate cut in autumn next year, there may yet be some further weakness in prices with the economy likely to fall into recession and unemployment to tick up.\n\n07:29 AM GMT\n\nHouse prices 'may well have bottomed out'\n\nHouse prices are on the rise again, economists have",
                            "sentiment": -0.8176,
                            "highlighted_in": "main_text"
                        }
                    ]
                }
            ],
            "similar": [
                {
                    "uuid": "7a6479cb-3e4a-4b6c-8bdc-830db2f3e529",
                    "title": "Swedish court rules against Tesla in dispute with postal service over deliveries By Reuters",
                    "description": "Swedish court rules against Tesla in dispute with postal service over deliveries",
                    "keywords": "",
                    "snippet": "Published Dec 07, 2023 09:38AM ET\n\n© Reuters. FILE PHOTO: Emma Hansson, chairman of IF Metall Stockholms lan, stands on strike outside Tesla's Service Center i...",
                    "url": "https://www.investing.com/news/stock-market-news/swedish-court-rules-against-tesla-in-dispute-with-postal-service-over-deliveries-3251757",
                    "image_url": "https://i-invdn-com.investing.com/news/LYNXNPEC6Q03Q_L.jpg",
                    "language": "en",
                    "published_at": "2023-12-07T14:41:33.000000Z",
                    "source": "investing.com",
                    "relevance_score": null,
                    "entities": [
                        {
                            "symbol": "TSLA",
                            "name": "Tesla, Inc.",
                            "exchange": null,
                            "exchange_long": null,
                            "country": "us",
                            "type": "equity",
                            "industry": "Consumer Cyclical",
                            "match_score": 24.19453,
                            "sentiment_score": -0.019238,
                            "highlights": [
                                {
                                    "highlight": "FILE PHOTO: Emma Hansson, chairman of IF Metall Stockholms lan, stands on strike outside Tesla's Service Center in Segeltorp, as workshop workers at the electric car company Tesla have gone on strike demanding that the company sign a collective agreement,\n\nTSLA -0.69% Add to/Remove from Watchlist\n\nSTOCKHOLM (Reuters) - Tesla (NASDAQ: ) lost a legal",
                                    "sentiment": -0.128,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "A Swedish court said PostNord does not for the time being need to deliver licence plates to Tesla that are being blocked by the postal service's workers, in the latest twist in a fight over collective bargaining agreements.",
                                    "sentiment": -0.3818,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "Tesla is facing growing pressure in Sweden, Norway and Denmark from unions backing Swedish IF Metall's mechanics who went on strike on Oct. 27 demanding a collective agreement with the company. A large Danish pension fund on Wednesday said it would sell its holdings in Tesla over its refusal to enter into such deals.",
                                    "sentiment": 0.1027,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "The court's decision on Thursday comes after Tesla sued PostNord as workers stopped delivering plates for its new cars in a sympathy strike, and is an interim decision ahead of the court's final ruling.",
                                    "sentiment": 0.0258,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "\"The district court has decided that PostNord should not be forced make deliveries to Tesla before the case is closed,\" the Solna district court said in a statement. Dockworkers, drivers, electricians and cleaners are other workers who refuse, or are threatening to refuse, to service Tesla in sympathy with IF Metall.",
                                    "sentiment": -0.5739,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "The Nordics is a key market for Tesla, which has a policy of not agreeing to collective bargaining and has said its staff have as good or better terms than those IF Metall is demanding. Last year, Norway was Tesla's fourth-biggest market by number of new car sales.",
                                    "sentiment": 0.5845,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "In a case related to the PostNord case, a court on Nov. 27 ruled that Sweden's transport authority must find a way to get licence plates to Tesla. The agency has appealed the decision. Some Swedish pension funds have urged Tesla to sign the agreement with the union, but so far held off selling its shares.",
                                    "sentiment": 0.6187,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "Swedish court rules against Tesla in dispute with postal service over deliveries By Reuters",
                                    "sentiment": -0.4019,
                                    "highlighted_in": "title"
                                }
                            ]
                        }
                    ]
                },
                {
                    "uuid": "63050534-6da3-4c51-afea-88941c9f5f24",
                    "title": "Factbox-Tesla labour dispute ignites Nordic sympathy strikes By Reuters",
                    "description": "Factbox-Tesla labour dispute ignites Nordic sympathy strikes",
                    "keywords": "",
                    "snippet": "Published Dec 07, 2023 07:21AM ET\n\n© Reuters. FILE PHOTO: A general view of a Tesla store in Porsgrunn, Norway, December 24, 2021. Picture taken December 24, 2...",
                    "url": "https://www.investing.com/news/stock-market-news/factboxtesla-labour-dispute-ignites-nordic-sympathy-strikes-3251566",
                    "image_url": "https://i-invdn-com.investing.com/news/Tesla_800x533_L_1608132047.jpg",
                    "language": "en",
                    "published_at": "2023-12-07T12:25:41.000000Z",
                    "source": "investing.com",
                    "relevance_score": null,
                    "entities": [
                        {
                            "symbol": "TSLA",
                            "name": "Tesla, Inc.",
                            "exchange": null,
                            "exchange_long": null,
                            "country": "us",
                            "type": "equity",
                            "industry": "Consumer Cyclical",
                            "match_score": 26.393465,
                            "sentiment_score": -0.095955,
                            "highlights": [
                                {
                                    "highlight": "FILE PHOTO: A general view of a Tesla store in Porsgrunn, Norway, December 24, 2021. Picture taken December 24, 2021.",
                                    "sentiment": 0,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "REUTERS/Victoria Klesty\n\nTSLA +0.27% Add to/Remove from Watchlist\n\n(Reuters) - A labour dispute between Tesla (NASDAQ: ) and Swedish trade union IF Metall has drawn in a host of unions across the Nordic region, all urging the automaker to sign a collective bargaining agreement.",
                                    "sentiment": 0.128,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "Here is an overview of sympathy actions that are adding pressure on Tesla by potentially disrupting its supply chain in Sweden, where Tesla's Model Y is the most sold new car so far this year:\n\nSWEDEN\n\nSweden's transport workers' union pledged in November to block loading and unloading of Tesla cars across the country's ports.",
                                    "sentiment": -0.3818,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "A dockworkers' union also said it would not handle Tesla cars in Swedish harbours from Nov. 17.",
                                    "sentiment": 0,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "The union of civil servants said its members at PostNord, owned by the Swedish and Danish states, would pause deliveries to Tesla from Nov. 21.\n\nThe electricians' union vowed in November to block electrical reparation works at Tesla facilities and charging stations, and painters union warned it planned to stop painting of Tesla cars.",
                                    "sentiment": -0.7351,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "The building maintenance workers' union halted all work related to the automaker from Nov. 17, while a building workers' union pledged to halt maintenance and construction work at Tesla service workshops.",
                                    "sentiment": 0,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "Unionised workers at Hydro Extrusions, a subsidiary of Norwegian aluminium and energy company Hydro, stopped work on Tesla car products from Nov. 24. The workers are members of IF Metall.\n\nSweden's musicians' union said on Nov. 14 it would block some music from Tesla cars' media systems.",
                                    "sentiment": -0.4019,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "NORWAY\n\nNorway's largest private sector labour union said on Dec. 6 it would start blocking transit shipments of Tesla cars meant for the Swedish market from Dec. 20 unless the EV-maker reaches an agreement with IF Metall.",
                                    "sentiment": 0.2023,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "The union said it intended to send a \"clear signal to Tesla\" and do what was necessary to ensure that any vehicle shipments via Norway to Sweden were blocked, but declined to say exactly which measures it might take.\n\nDENMARK\n\nDanish dockworkers' union said on Dec. 5 it would not unload or transport cars made by Tesla for Swedish customers.",
                                    "sentiment": 0.2617,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "PensionDanmark, one of Denmark's largest pension funds, said on Dec. 6 it had decided to sell its holdings in Tesla over the automaker's refusal to enter into agreements with labour unions.",
                                    "sentiment": 0.2732,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "Factbox-Tesla labour dispute ignites Nordic sympathy strikes By Reuters",
                                    "sentiment": -0.4019,
                                    "highlighted_in": "title"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "uuid": "95788e7d-65ea-4c57-a9b1-54d29e5a9777",
            "title": "AbbVie's $8.7 billion bet on Cerevel is risky but smart, analysts say By Reuters",
            "description": "AbbVie's $8.7 billion bet on Cerevel is risky but smart, analysts say",
            "keywords": "",
            "snippet": "Published Dec 07, 2023 01:34PM ET\n\n© Reuters. FILE PHOTO: A sign stands outside a Abbvie facility in Cambridge, Massachusetts, U.S., May 20, 2021. REUTERS/Bria...",
            "url": "https://www.investing.com/news/stock-market-news/abbvies-87-billion-bet-on-cerevel-is-risky-but-smart-analysts-say-3251944",
            "image_url": "https://i-invdn-com.investing.com/news/moved_LYNXMPEHAF0J7_L.jpg",
            "language": "en",
            "published_at": "2023-12-07T18:38:42.000000Z",
            "source": "investing.com",
            "relevance_score": null,
            "entities": [
                {
                    "symbol": "KRTX",
                    "name": "Karuna Therapeutics, Inc.",
                    "exchange": null,
                    "exchange_long": null,
                    "country": "us",
                    "type": "equity",
                    "industry": "Healthcare",
                    "match_score": 23.429974,
                    "sentiment_score": -0.3182,
                    "highlights": [
                        {
                            "highlight": "Adding to concerns, schizophrenia drug trials have had a historically higher chance of failure compared to most other disease spaces, and Cerevel's rival Karuna Therapeutics (NASDAQ: ) has a two-year lead on emraclidine.\n\nBut the payoff could be high, analysts and investors said.",
                            "sentiment": -0.3182,
                            "highlighted_in": "main_text"
                        }
                    ]
                }
            ],
            "similar": [
                {
                    "uuid": "9220bae0-0497-41b9-b830-712b88864f86",
                    "title": "Bain scores over tenfold return with $8.7 billion Cerevel sale By Reuters",
                    "description": "Bain scores over tenfold return with $8.7 billion Cerevel sale",
                    "keywords": "",
                    "snippet": "Published Dec 07, 2023 12:41PM ET\n\n© Reuters. FILE PHOTO: The logo of Bain Capital is displayed on the screen during a news conference in Tokyo, Japan October ...",
                    "url": "https://www.investing.com/news/stock-market-news/bain-scores-over-tenfold-return-with-87-billion-cerevel-sale-3251925",
                    "image_url": "https://i-invdn-com.investing.com/news/LYNXMPEB2C0AG_L.jpg",
                    "language": "en",
                    "published_at": "2023-12-07T17:46:01.000000Z",
                    "source": "investing.com",
                    "relevance_score": null,
                    "entities": [
                        {
                            "symbol": "ABBV34.SA",
                            "name": "AbbVie Inc.",
                            "exchange": null,
                            "exchange_long": null,
                            "country": "br",
                            "type": "equity",
                            "industry": "Healthcare",
                            "match_score": 26.994293,
                            "sentiment_score": 0.133967,
                            "highlights": [
                                {
                                    "highlight": "REUTERS/Kim Kyung-Hoon/File Photo\n\nPFE -0.03% Add to/Remove from Watchlist ABBV +0.79% Add to/Remove from Watchlist\n\nBy Greg Roumeliotis\n\n(Reuters) - Private equity firm Bain Capital stands to make more than 10 times the $250 million it invested in Cerevel Therapeutics Holdings Inc following the neurology-focused drug developer's $8.7 billion sale to AbbVie",
                                    "sentiment": 0,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "Inc (NYSE: ), according to regulatory filings.",
                                    "sentiment": 0,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "The deal with AbbVie, announced on Tuesday, now values Bain's 36.5% stake in Cerevel at about $2.7 billion.\n\nThis more than tenfold return is significantly higher than the private equity industry's average return on invested capital in the healthcare sector of 2.9 times, according to investment advisor Cambridge Associates.",
                                    "sentiment": 0.4019,
                                    "highlighted_in": "main_text"
                                }
                            ]
                        },
                        {
                            "symbol": "ABBV",
                            "name": "AbbVie Inc.",
                            "exchange": null,
                            "exchange_long": null,
                            "country": "us",
                            "type": "equity",
                            "industry": "Healthcare",
                            "match_score": 34.0148,
                            "sentiment_score": 0.133967,
                            "highlights": [
                                {
                                    "highlight": "REUTERS/Kim Kyung-Hoon/File Photo\n\nPFE -0.03% Add to/Remove from Watchlist ABBV +0.79% Add to/Remove from Watchlist\n\nBy Greg Roumeliotis\n\n(Reuters) - Private equity firm Bain Capital stands to make more than 10 times the $250 million it invested in Cerevel Therapeutics Holdings Inc following the neurology-focused drug developer's $8.7 billion sale to AbbVie",
                                    "sentiment": 0,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "Inc (NYSE: ), according to regulatory filings.",
                                    "sentiment": 0,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "The deal with AbbVie, announced on Tuesday, now values Bain's 36.5% stake in Cerevel at about $2.7 billion.\n\nThis more than tenfold return is significantly higher than the private equity industry's average return on invested capital in the healthcare sector of 2.9 times, according to investment advisor Cambridge Associates.",
                                    "sentiment": 0.4019,
                                    "highlighted_in": "main_text"
                                }
                            ]
                        },
                        {
                            "symbol": "PFE",
                            "name": "Pfizer Inc.",
                            "exchange": null,
                            "exchange_long": null,
                            "country": "us",
                            "type": "equity",
                            "industry": "Healthcare",
                            "match_score": 28.221542,
                            "sentiment_score": 0.73255,
                            "highlights": [
                                {
                                    "highlight": "Boston-based Bain committed $350 million in 2018 to carve Cambridge, Massachusetts-based Cerevel out of Pfizer Inc (NYSE: ), but only $250 million of that was drawn, the filings show. The deal with AbbVie, announced on Tuesday, now values Bain's 36.5% stake in Cerevel at about $2.7 billion.",
                                    "sentiment": 0.6249,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "Bain and Pfizer, which retained a 15% stake in Cerevel, took the company public in 2020 through the merger with a special purpose acquisition vehicle. It was one of the few such deals to have proved successful, as most companies that went public through that route in the past three years now trade at a fraction of their deal value.",
                                    "sentiment": 0.8402,
                                    "highlighted_in": "main_text"
                                }
                            ]
                        },
                        {
                            "symbol": "PFE-WI",
                            "name": "Pfizer, Inc.",
                            "exchange": null,
                            "exchange_long": null,
                            "country": "us",
                            "type": "equity",
                            "industry": "N/A",
                            "match_score": 28.221542,
                            "sentiment_score": 0.73255,
                            "highlights": [
                                {
                                    "highlight": "Boston-based Bain committed $350 million in 2018 to carve Cambridge, Massachusetts-based Cerevel out of Pfizer Inc (NYSE: ), but only $250 million of that was drawn, the filings show. The deal with AbbVie, announced on Tuesday, now values Bain's 36.5% stake in Cerevel at about $2.7 billion.",
                                    "sentiment": 0.6249,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "Bain and Pfizer, which retained a 15% stake in Cerevel, took the company public in 2020 through the merger with a special purpose acquisition vehicle. It was one of the few such deals to have proved successful, as most companies that went public through that route in the past three years now trade at a fraction of their deal value.",
                                    "sentiment": 0.8402,
                                    "highlighted_in": "main_text"
                                }
                            ]
                        },
                        {
                            "symbol": "PFED.BA",
                            "name": "PFIZER INC",
                            "exchange": null,
                            "exchange_long": null,
                            "country": "ar",
                            "type": "equity",
                            "industry": "N/A",
                            "match_score": 21.19859,
                            "sentiment_score": 0.73255,
                            "highlights": [
                                {
                                    "highlight": "Boston-based Bain committed $350 million in 2018 to carve Cambridge, Massachusetts-based Cerevel out of Pfizer Inc (NYSE: ), but only $250 million of that was drawn, the filings show. The deal with AbbVie, announced on Tuesday, now values Bain's 36.5% stake in Cerevel at about $2.7 billion.",
                                    "sentiment": 0.6249,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "Bain and Pfizer, which retained a 15% stake in Cerevel, took the company public in 2020 through the merger with a special purpose acquisition vehicle. It was one of the few such deals to have proved successful, as most companies that went public through that route in the past three years now trade at a fraction of their deal value.",
                                    "sentiment": 0.8402,
                                    "highlighted_in": "main_text"
                                }
                            ]
                        },
                        {
                            "symbol": "ABBV.BA",
                            "name": "AbbVie Inc.",
                            "exchange": null,
                            "exchange_long": null,
                            "country": "ar",
                            "type": "equity",
                            "industry": "N/A",
                            "match_score": 26.985115,
                            "sentiment_score": 0.133967,
                            "highlights": [
                                {
                                    "highlight": "REUTERS/Kim Kyung-Hoon/File Photo\n\nPFE -0.03% Add to/Remove from Watchlist ABBV +0.79% Add to/Remove from Watchlist\n\nBy Greg Roumeliotis\n\n(Reuters) - Private equity firm Bain Capital stands to make more than 10 times the $250 million it invested in Cerevel Therapeutics Holdings Inc following the neurology-focused drug developer's $8.7 billion sale to AbbVie",
                                    "sentiment": 0,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "Inc (NYSE: ), according to regulatory filings.",
                                    "sentiment": 0,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "The deal with AbbVie, announced on Tuesday, now values Bain's 36.5% stake in Cerevel at about $2.7 billion.\n\nThis more than tenfold return is significantly higher than the private equity industry's average return on invested capital in the healthcare sector of 2.9 times, according to investment advisor Cambridge Associates.",
                                    "sentiment": 0.4019,
                                    "highlighted_in": "main_text"
                                }
                            ]
                        },
                        {
                            "symbol": "ABBVD.BA",
                            "name": "ABBVIE INC",
                            "exchange": null,
                            "exchange_long": null,
                            "country": "ar",
                            "type": "equity",
                            "industry": "N/A",
                            "match_score": 26.985115,
                            "sentiment_score": 0.133967,
                            "highlights": [
                                {
                                    "highlight": "REUTERS/Kim Kyung-Hoon/File Photo\n\nPFE -0.03% Add to/Remove from Watchlist ABBV +0.79% Add to/Remove from Watchlist\n\nBy Greg Roumeliotis\n\n(Reuters) - Private equity firm Bain Capital stands to make more than 10 times the $250 million it invested in Cerevel Therapeutics Holdings Inc following the neurology-focused drug developer's $8.7 billion sale to AbbVie",
                                    "sentiment": 0,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "Inc (NYSE: ), according to regulatory filings.",
                                    "sentiment": 0,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "The deal with AbbVie, announced on Tuesday, now values Bain's 36.5% stake in Cerevel at about $2.7 billion.\n\nThis more than tenfold return is significantly higher than the private equity industry's average return on invested capital in the healthcare sector of 2.9 times, according to investment advisor Cambridge Associates.",
                                    "sentiment": 0.4019,
                                    "highlighted_in": "main_text"
                                }
                            ]
                        },
                        {
                            "symbol": "PFECL.SN",
                            "name": "PFIZER INC",
                            "exchange": null,
                            "exchange_long": null,
                            "country": "cl",
                            "type": "equity",
                            "industry": "N/A",
                            "match_score": 21.198345,
                            "sentiment_score": 0.73255,
                            "highlights": [
                                {
                                    "highlight": "Boston-based Bain committed $350 million in 2018 to carve Cambridge, Massachusetts-based Cerevel out of Pfizer Inc (NYSE: ), but only $250 million of that was drawn, the filings show. The deal with AbbVie, announced on Tuesday, now values Bain's 36.5% stake in Cerevel at about $2.7 billion.",
                                    "sentiment": 0.6249,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "Bain and Pfizer, which retained a 15% stake in Cerevel, took the company public in 2020 through the merger with a special purpose acquisition vehicle. It was one of the few such deals to have proved successful, as most companies that went public through that route in the past three years now trade at a fraction of their deal value.",
                                    "sentiment": 0.8402,
                                    "highlighted_in": "main_text"
                                }
                            ]
                        },
                        {
                            "symbol": "PFE.SN",
                            "name": "Pfizer Inc.",
                            "exchange": null,
                            "exchange_long": null,
                            "country": "cl",
                            "type": "equity",
                            "industry": "Healthcare",
                            "match_score": 21.198284,
                            "sentiment_score": 0.73255,
                            "highlights": [
                                {
                                    "highlight": "Boston-based Bain committed $350 million in 2018 to carve Cambridge, Massachusetts-based Cerevel out of Pfizer Inc (NYSE: ), but only $250 million of that was drawn, the filings show. The deal with AbbVie, announced on Tuesday, now values Bain's 36.5% stake in Cerevel at about $2.7 billion.",
                                    "sentiment": 0.6249,
                                    "highlighted_in": "main_text"
                                },
                                {
                                    "highlight": "Bain and Pfizer, which retained a 15% stake in Cerevel, took the company public in 2020 through the merger with a special purpose acquisition vehicle. It was one of the few such deals to have proved successful, as most companies that went public through that route in the past three years now trade at a fraction of their deal value.",
                                    "sentiment": 0.8402,
                                    "highlighted_in": "main_text"
                                }
                            ]
                        },
                        {
                            "symbol": "CERE",
                            "name": "Cerevel Therapeutics Holdings, Inc.",
                            "exchange": null,
                            "exchange_long": null,
                            "country": "us",
                            "type": "equity",
                            "industry": "Healthcare",
                            "match_score": 55.688354,
                            "sentiment_score": 0,
                            "highlights": [
                                {
                                    "highlight": "REUTERS/Kim Kyung-Hoon/File Photo\n\nPFE -0.03% Add to/Remove from Watchlist ABBV +0.79% Add to/Remove from Watchlist\n\nBy Greg Roumeliotis\n\n(Reuters) - Private equity firm Bain Capital stands to make more than 10 times the $250 million it invested in Cerevel Therapeutics Holdings Inc following the neurology-focused drug developer's $8.7 billion sale to",
                                    "sentiment": 0,
                                    "highlighted_in": "main_text"
                                }
                            ]
                        },
                        {
                            "symbol": "CEREW",
                            "name": "Cerevel Therapeutics Holdings, Inc.",
                            "exchange": null,
                            "exchange_long": null,
                            "country": "us",
                            "type": "equity",
                            "industry": "N/A",
                            "match_score": 55.656544,
                            "sentiment_score": 0,
                            "highlights": [
                                {
                                    "highlight": "REUTERS/Kim Kyung-Hoon/File Photo\n\nPFE -0.03% Add to/Remove from Watchlist ABBV +0.79% Add to/Remove from Watchlist\n\nBy Greg Roumeliotis\n\n(Reuters) - Private equity firm Bain Capital stands to make more than 10 times the $250 million it invested in Cerevel Therapeutics Holdings Inc following the neurology-focused drug developer's $8.7 billion sale to",
                                    "sentiment": 0,
                                    "highlighted_in": "main_text"
                                }
                            ]
                        }
                    ]
                }
            ]
        }
    ]
}
                                        
                                    

Example response